Should I Buy NUTX? NUTX 2026 Analysis

Should You Buy Nutex Health Inc (NUTX) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion

Hold

Latest Price

148.530

1 Day change

-0.85%

52 Week Range

193.070

Analysis Updated At

2026/01/26

Nutex Health Inc (NUTX) is not a strong buy at the moment for a beginner investor with a long-term strategy. The technical indicators are neutral, there are no positive trading signals, and the financial performance shows significant net income and EPS declines despite revenue growth. Additionally, there are no recent news catalysts or influential trading activity to support a buy decision.

Technical Analysis

The MACD histogram is negative (-3.533) and contracting, RSI is neutral at 42.09, and moving averages are converging. The stock is trading below the pivot level (165.644) with support levels at 146.185 and 134.164, indicating potential downside risk. Historical patterns suggest a likelihood of short-term declines (-1.05% next day, -3.73% next week) with a potential recovery (+6.57%) over the next month.

Options Data

Positive Catalysts

Gross margin improved by 107.87% YoY to 57.83%.

Neutral/Negative Catalysts

No recent news or significant insider/hedge fund trading activity. Technical indicators do not show a clear upward trend.

Financial Performance

In Q3 2025, revenue increased to $267.8M (+239.87% YoY), but net income dropped to $55.4M (-730.78% YoY), and EPS fell to 7.76 (-551.16% YoY). Gross margin improved to 57.83% (+107.87% YoY).

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No recent analyst ratings or price target changes available.

2 Analyst Rating

Wall Street analysts forecast NUTX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NUTX is 265 USD with a low forecast of 230 USD and a high forecast of 300 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

2 Buy

0 Hold

0 Sell

Moderate Buy

Current: 149.800

Low

230

Averages

265

High

300

Current: 149.800

Low

230

Averages

265

High

300

Maxim

Buy

downgrade

$225 -> $205

AI Analysis

2025-08-26

Reason

Maxim

Price Target

$225 -> $205

AI Analysis

2025-08-26

downgrade

Buy

Reason

Maxim lowered the firm's price target on Nutex Health to $205 from $225 and keeps a Buy rating on the shares. On August 14th, the company filed an NT 10-Q notification of inability to timely file its 10-Q for the three months ended 6/30/25, due to the incorrect accounting classification of certain non-cash obligations, the analyst tells investors in a research note. The firm views the accounting restatements, arbitration dynamics, and lawsuits against Nutex's primary arbitration vendor, HaloMD, as potential headwinds to the stock price, Maxim added.

Maxim

Buy

maintain

$100 -> $225

2025-05-20

Reason

Maxim

Price Target

$100 -> $225

2025-05-20

maintain

Buy

Reason

NUTX Should I Buy

NUTX Should I Buy

Should You Buy Nutex Health Inc (NUTX) Today? Analysis, Price Targets, and 2026 Outlook.

Technical Analysis

Options Data

Positive Catalysts

Neutral/Negative Catalysts

Financial Performance

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

People Also Watch